1. Home
  2. PTIX vs ISPC Comparison

PTIX vs ISPC Comparison

Compare PTIX & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • ISPC
  • Stock Information
  • Founded
  • PTIX 1994
  • ISPC 2009
  • Country
  • PTIX United States
  • ISPC United States
  • Employees
  • PTIX N/A
  • ISPC N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • ISPC Precision Instruments
  • Sector
  • PTIX Health Care
  • ISPC Health Care
  • Exchange
  • PTIX Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • PTIX 2.0M
  • ISPC 2.0M
  • IPO Year
  • PTIX 2016
  • ISPC 2021
  • Fundamental
  • Price
  • PTIX $0.27
  • ISPC $1.74
  • Analyst Decision
  • PTIX
  • ISPC
  • Analyst Count
  • PTIX 0
  • ISPC 0
  • Target Price
  • PTIX N/A
  • ISPC N/A
  • AVG Volume (30 Days)
  • PTIX 599.7K
  • ISPC 120.7K
  • Earning Date
  • PTIX 03-31-2025
  • ISPC 03-12-2025
  • Dividend Yield
  • PTIX N/A
  • ISPC N/A
  • EPS Growth
  • PTIX N/A
  • ISPC N/A
  • EPS
  • PTIX N/A
  • ISPC N/A
  • Revenue
  • PTIX N/A
  • ISPC $10,390,702.00
  • Revenue This Year
  • PTIX N/A
  • ISPC $13.82
  • Revenue Next Year
  • PTIX N/A
  • ISPC $11.76
  • P/E Ratio
  • PTIX N/A
  • ISPC N/A
  • Revenue Growth
  • PTIX N/A
  • ISPC 0.74
  • 52 Week Low
  • PTIX $0.25
  • ISPC $1.73
  • 52 Week High
  • PTIX $1.87
  • ISPC $11.80
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 34.94
  • ISPC 32.34
  • Support Level
  • PTIX $0.25
  • ISPC $1.76
  • Resistance Level
  • PTIX $0.30
  • ISPC $1.99
  • Average True Range (ATR)
  • PTIX 0.03
  • ISPC 0.16
  • MACD
  • PTIX 0.00
  • ISPC 0.02
  • Stochastic Oscillator
  • PTIX 10.43
  • ISPC 2.13

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: